Financial

Artio Medical Closes $28M in Additional Series A Financing

Funding to launch commercial sales team in US and continue development of best-in-class product pipeline PRAIRIE VILLAGE, Kan., June 16, 2022 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, […]

Aerami Therapeutics Appoints Lisa Yañez as Chief Operating Officer

DURHAM, N.C., June 16, 2022 (GLOBE NEWSWIRE) — Aerami Therapeutics, Inc. (the “Company”), a biopharmaceutical company focused on developing inhaled therapies to treat severe respiratory and other chronic diseases, today announces the appointment of Lisa Yañez as chief operating officer.   Ms. Yañez brings more than 25 years of leadership experience helping to advance […]

Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-In-Class Cardiovascular Therapeutics

Facility to Provide Clinical Supply of Lead Gene Therapy Programs TN-201 and TN-401 for Planned First-in-Human Studies 94,000 sq. ft. Modular Facility has Initial Production Capacity at the 1000L Scale SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver […]

Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd

MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, (“M.I.Tech”) a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and […]

Pulnovo Medical Announces Dr. Krishna Sudhir Joins Scientific Advisory Board

SHANGHAI, June 15, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM innovation platform, recently announced that Dr. Krishna Sudhir has officially joined the Pulnovo Medical Scientific Advisory Board. Dr. Krishna Sudhir will provide scientific guidance and take an important part in the innovation and internationalization of Pulnovo Medical’s technology platforms and R&D portfolio.   Dr. Sudhir […]

Bodyport Appoints John Lipman as Chief Executive Officer

Medtech industry veteran to lead Bodyport market entry and growth of noninvasive tool to assess heart function and fluid status easily at home SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, today announced the appointment of medtech industry veteran, John Lipman, as Chief Executive […]

Ablative Solutions, Inc. Announces Completion of the Fourth Tranche of its Series D Preferred Financing Round for Unique Therapeutic Approach to Treating Uncontrolled Hypertension

WAKEFIELD, Mass., June 13, 2022 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of the fourth tranche of its Series D financing round, resulting in $91.4 million in aggregate proceeds to the Company from the Series D financing round. Gilde Healthcare, BioStar Capital, Invus […]

Verve Therapeutics Appoints Experienced Biotechnology Executive, Alexander G. “Bo” Cumbo, to its Board of Directors

CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Alexander G. “Bo” Cumbo, chief executive officer and president of AavantiBio, Inc., has joined the company’s board of directors. “Bo […]